BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26864050)

  • 1. DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.
    Flörcken A; Kopp J; Kölsch U; Meisel C; Dörken B; Pezzutto A; Westermann J
    Hum Vaccin Immunother; 2016 May; 12(5):1117-23. PubMed ID: 26864050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro cytokines-induced differentiation in mononuclear cell derived dendritic cells from chronic myeloid leukemia].
    Zhang YF; Wu CY; Zhang LS; Chai Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):137-41. PubMed ID: 16584610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
    Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
    Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
    Hus I; Tabarkiewicz J; Lewandowska M; Wasiak M; Wdowiak P; Kusz M; Legieć M; Dmoszyńska A; Roliński J
    Folia Histochem Cytobiol; 2011; 49(1):153-60. PubMed ID: 21526503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment.
    Gabriele L; Borghi P; Rozera C; Sestili P; Andreotti M; Guarini A; Montefusco E; Foà R; Belardelli F
    Blood; 2004 Feb; 103(3):980-7. PubMed ID: 14525781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
    Eisendle K; Lang A; Eibl B; Nachbaur D; Glassl H; Fiegl M; Thaler J; Gastl G
    Br J Haematol; 2003 Jan; 120(1):63-73. PubMed ID: 12492578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of IFN-alpha on function of CML-DC in vitro and expression of chemokine with its receptor].
    Zhai XH; Xing PN; Wei XC; Zhao WL; Li MS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):488-91. PubMed ID: 15972148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response.
    Eibl B; Ebner S; Duba C; Böck G; Romani N; Erdel M; Gächter A; Niederwieser D; Schuler G
    Genes Chromosomes Cancer; 1997 Nov; 20(3):215-23. PubMed ID: 9365828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of PD-L1 blockade on function of dendritic cells derived from chronic myelocytic leukemia].
    Wang CY; Zhang LS; Tian FQ; Huang R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1146-9. PubMed ID: 18928614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis.
    Korthals M; Safaian N; Kronenwett R; Maihöfer D; Schott M; Papewalis C; Diaz Blanco E; Winter M; Czibere A; Haas R; Kobbe G; Fenk R
    J Transl Med; 2007 Sep; 5():46. PubMed ID: 17894866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells.
    Dietz AB; Litzow MR; Bulur PA; Vuk-Pavlović S
    Cytotherapy; 2001; 3(2):97-105. PubMed ID: 12028832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of astragalus polysaccharide on the function and maturation of plasmacytoid dendritic cells from chronic myelogenous leukemia before and after treatment].
    Liu LM; Zhang LS
    Zhonghua Xue Ye Xue Za Zhi; 2010 Nov; 31(11):740-3. PubMed ID: 21223727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
    Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
    J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells.
    Nagai T; Devergne O; van Seventer GA; van Seventer JM
    Scand J Immunol; 2007 Feb; 65(2):107-17. PubMed ID: 17257215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.
    Litzow MR; Dietz AB; Bulur PA; Butler GW; Gastineau DA; Hoering A; Fink SR; Letendre L; Padley DJ; Paternoster SF; Tefferi A; Vuk-Pavlović S
    Cytotherapy; 2006; 8(3):290-8. PubMed ID: 16793737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion.
    Bartholomé EJ; Willems F; Crusiaux A; Thielemans K; Schandene L; Goldman M
    J Interferon Cytokine Res; 1999 May; 19(5):471-8. PubMed ID: 10386859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.